StonvexLoading…
StonvexStonvexStonvexCore line items from MRVL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $8.19B | $5.77B | $5.51B | $5.92B |
Operating Income | $1.32B | $-720.30M | $-567.70M | $238.00M |
Net Income | $2.67B | $-885.00M | $-933.40M | $-163.50M |
EPS (Diluted) | $3.07 | $-1.02 | $-1.08 | $-0.19 |
Total Assets | $22.29B | $20.20B | $21.23B | $22.52B |
Total Liabilities | $7.98B | $6.78B | $6.40B | $6.88B |
Cash & Equivalents | $2.64B | $948.30M | $950.80M | $911.00M |
Free Cash Flow OCF − CapEx | $1.40B | $1.40B | $1.03B | $1.08B |
Shares Outstanding | 847.30M | 866.00M | 865.50M | 856.10M |